Hebei Changshan Biochem Pharma Cash Flow Quality Index
Hebei Changshan Biochem Pharma cash flow quality index. Hebei Changshan Biochem Pharma (300255) has a Cash Flow Quality Index of 27.23x as of March 2025. Operating cash flow of CN¥102.99 Million exceeds net income of CN¥3.78 Million, indicating high earnings quality where cash backs reported profits. See Hebei Changshan Biochem Pharma free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hebei Changshan Biochem Pharma (2008–2022)
Cash flow quality index of Hebei Changshan Biochem Pharma from 2008 to 2022. Historical Cash Flow Quality Index for Hebei Changshan Biochem Pharma across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 300255 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Hebei Changshan Biochem Pharma Cash Flow Quality Index by Year (2008–2022)
Hebei Changshan Biochem Pharma cash flow quality index by year from 2008 to 2022. Year-by-year earnings quality comparison for Hebei Changshan Biochem Pharma. For the full cash flow conversion analysis, see Hebei Changshan Biochem Pharma cash conversion from operations.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.31x | CN¥3.13 Million | CN¥10.16 Million | ▲ +2378.5% |
| 2021 | 0.01x | CN¥2.87 Million | CN¥231.26 Million | ▲ +101.7% |
| 2020 | -0.73x | CN¥-183.58 Million | CN¥251.14 Million | ▼ -179.7% |
| 2019 | -0.26x | CN¥-58.13 Million | CN¥222.43 Million | ▼ -111.8% |
| 2018 | 2.21x | CN¥292.81 Million | CN¥132.21 Million | ▲ +176.1% |
| 2017 | 0.80x | CN¥162.28 Million | CN¥202.31 Million | ▼ -16.8% |
| 2016 | 0.96x | CN¥171.96 Million | CN¥178.32 Million | ▲ +496.2% |
| 2015 | -0.24x | CN¥-38.14 Million | CN¥156.67 Million | ▲ +61.5% |
| 2014 | -0.63x | CN¥-84.97 Million | CN¥134.32 Million | ▼ -378.1% |
| 2013 | -0.13x | CN¥-15.24 Million | CN¥115.22 Million | ▲ +81.5% |
| 2012 | -0.71x | CN¥-70.62 Million | CN¥98.99 Million | ▼ -396.4% |
| 2011 | 0.24x | CN¥17.04 Million | CN¥70.80 Million | ▼ -50.5% |
| 2010 | 0.49x | CN¥29.25 Million | CN¥60.19 Million | ▼ -27.0% |
| 2009 | 0.67x | CN¥24.21 Million | CN¥36.37 Million | ▲ +120.0% |
| 2008 | -3.32x | CN¥-30.83 Million | CN¥9.28 Million | — |